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he X-linked mammalian inhibitor of apoptosis protein
(XIAP) has been shown to bind several partners.
These partners include caspase 3, caspase 9, DIABLO/
Smac, HtrA2/Omi, TAB1, the bone morphogenetic protein
receptor, and a presumptive E2 ubiquitin-conjugating
enzyme. In addition, we show here that XIAP can bind to
itself. To determine which of these interactions are required
for it to inhibit apoptosis, we generated point mutant XIAP
proteins and correlated their ability to bind other proteins
with their ability to inhibit apoptosis. 
 
 
 
RING point mutants
T
 
of XIAP were as competent as their full-length counterparts
in inhibiting apoptosis, although impaired in their ability to
oligomerize with full-length XIAP. Triple point mutants,
unable to bind caspase 9, caspase 3, and DIABLO/HtrA2/
Omi, were completely ineffectual in inhibiting apoptosis.
However, point mutants that had lost the ability to inhibit
caspase 9 and caspase 3 but retained the ability to inhibit
DIABLO were still able to inhibit apoptosis, demonstrating
that IAP antagonism is required for apoptosis to proceed
following UV irradiation.
 
Introduction
 
All IAPs* bear baculoviral IAP repeats (BIRs), zinc-binding
folds of 
 
 
 
70 amino acids (Deveraux and Reed, 1999; Silke
and Vaux, 2001). X-linked mammalian inhibitor of apopto-
sis protein (XIAP)/hILP/MIHA, c-iap1/MIHB, and c-iap2/
MIHC each bear three BIRs followed by a C-terminal
RING finger. The BIRs and the regions that flank them are
required for interaction of IAPs with tumor necrosis factor
(TNF) receptor- associated factors (TRAFs) 1 and 2, TAB1,
processed caspase 3, processed caspase 9, and processed
DIABLO/smac (Rothe et al., 1995; Deveraux et al., 1997;
Yamaguchi et al., 1999; Chai et al., 2000; Ekert et al.,
2001).
On the other hand, the RING finger domain of XIAP has
been shown to bind the bone morphogenetic protein recep-
tor 1A (Yamaguchi et al., 1999). The RING finger of XIAP
and c-iap1 has also been shown to function as an E3 ligase,
promoting IAP ubiquitination (Yang et al., 2000). There-
fore, the RING finger presumably binds to an as yet unidenti-
fied E2 ubiquitin-conjugating enzyme. The RING finger has
been described to play an essential role in preventing apop-
tosis because XIAP 
 
 
 
RING mutants were less effective at
blocking Fas-induced cell death (Suzuki et al., 2001).
Whereas mammalian IAPs have been shown to be able to
potently inhibit caspases, it remained possible that other
protein interactions were important for its ability to prevent
apoptosis, with the anti-caspase activity being redundant.
For example, the very similar OpIAP is incapable of inhibit-
ing viral- induced apoptosis when expressed without its
RING finger. Moreover, the 
 
 
 
RING protein appears to
dominantly interfere with full-length OpIAPs anti-apoptotic
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function even though it contains the BIRs that might medi-
ate caspase inhibition (Hozak et al., 2000). Other studies
have linked XIAPs ability to inhibit cell death to jnk1 activa-
tion (Sanna et al., 1998).
Many previous studies using IAPs have used mutants that
grossly disrupt structure of the BIR domains or the RING
finger, or alternatively utilized domains to assess the func-
tions of IAPs (Takahashi et al., 1998; Deveraux et al.,
1999). Data obtained from mutants that interfere with
gross structure have to be interpreted with care, and analy-
ses with domains have obvious drawbacks. Apart from the
fact that normally domains function within the whole pro-
tein and maybe regulated allosterically, it is difficult to
compare results between domains because of varying ex-
pression levels. Also, domains cannot be assumed to fold
correctly, and experiments with domains sometimes give
counter-intuitive results. For example, the BIR3 RING do-
main of XIAP antagonises Fas-induced cell death, and
when fused to GST the BIR3 RING domain binds the zy-
mogen pro–caspase 9 rather than the active processed cas-
pase 9 (Deveraux et al., 1999).
Although there is now a wealth of structural information
on the BIR domains (Sun et al., 1999, 2000; Liu et al.,
2000; Wu et al., 2000; Chai et al., 2001; Huang et al.,
2001; Riedl et al., 2001), IAP point mutants have not been
rigorously tested in their ability to inhibit apoptosis (Silke
et al., 2001; Suzuki et al., 2001). Using structurally sound
mutants, it is possible to test in a very precise manner
whether the ability of XIAP to inhibit apoptosis resides in
its ability to inhibit processed caspases or whether it also
has another anti-apoptotic activity distinct from its ability
to inhibit caspases.
Therefore, we constructed a panel of single point mu-
tants of XIAP that no longer bind to caspase 3 or caspase
9 or DIABLO, but maintain the structural integrity of
XIAP and its ability to oligomerize. To assess the impor-
tance of the RING finger we also expressed some of the
key point mutants without the RING finger. The C-ter-
minal end chosen for the 
 
 
 
RING constructs gives rise to a
correctly folded BIR3 domain (Sun et al., 2000); there-
fore, these particular deletion mutants should be correctly
folded.
Using two different death stimuli, we show that XIAP’s
ability to inhibit cell death is unimpaired if either the caspase
3 or caspase 9 binding activity is lost. Simultaneous disruption
of XIAP’s ability to bind caspase 3 and caspase 9 and DI-
ABLO completely abrogated its ability to inhibit apoptosis,
therefore XIAP requires only these three activities to inhibit
UV/etoposide-induced cell death. 
 
 
 
RING mutants which
were severely impaired in their ability to oligomerize with full-
length XIAP were as competent as full-length XIAP mutants
in inhibiting cell death, indicating that neither the RING, nor
oligomerization, are essential to XIAPs function. Interestingly,
mutants that had lost the ability to inhibit caspase 9 and cas-
pase 3 yet maintained their ability to bind DIABLO/smac
were able to inhibit cell death. These results indicate that en-
dogenous XIAP is sufficient to prevent apoptosis provided it is
not antagonized by an IAP antagonist such as DIABLO/smac,
revealing a requirement for IAP antagonism in this model
death system.
 
Results
 
In order to analyze the requirement for different protein in-
teractions for XIAP to inhibit cell death, we generated a
large number of single point mutants of XIAP. These point
mutant proteins have been examined by nuclear magnetic
resonance and do not affect the folding of the BIR domains
(Sun et al., 1999, 2000), and therefore should leave the
structure of the full length molecule intact (Fig. 1, top). As
the point mutations were designed to disrupt particular in-
teractions and were themselves based on domain analyses,
they have rarely been tested against other partners but are as-
sumed to specifically affect only the target partner (Fig. 1,
top). Previously published in vitro data for binding and in-
hibition of most of the mutants used in this study are tabu-
lated with details described in the figure legend.
 
XIAP interaction with processed caspase 3
 
We and others have previously described analysis of single
point mutations within the linker region between the BIR1
and BIR2 of XIAP including T143A, V146A, and D148A
(Sun et al., 1999; Silke et al., 2001) (Fig. 1, top). Full-length
XIAP bearing the D148A mutation to the linker N-terminal
of BIR2 cannot bind processed caspase 3 in coimmunopre-
cipitation analysis in vivo and its ability to inhibit caspase 3
in vitro is reduced 
 
 
 
500-fold (Silke et al., 2001).
Therefore, to confirm that all D148A mutants described
here had lost the ability to inhibit caspase 3, we performed im-
munoprecipitation analysis with FLAG-tagged XIAP in 293T
cells transfected with an autoactivating caspase 3-LacZ con-
struct that is toxic to 293 cells. The autoactivating caspase 3
LacZ is a convenient approach to obtain active processed cas-
pase 3, the partner of XIAP. All XIAPs used in this study that
carried the D148A mutation accumulated less caspase 3 be-
cause of the poor survival of cells containing unbound and
uninhibited caspase 3. All the other mutants without D148A
were able to bind active caspase 3 and accumulated more ac-
tive caspase 3. These observations are consistent with the idea
that if active caspase 3 is not inhibited, small amounts are suf-
ficient to kill the cell, leaving little time for processed caspase 3
to accumulate. Note the similar lack of processed caspase 3 in
the cells transfected with TAB1.
Interestingly, although structural studies (Riedl et al.,
2001) have shown that the processed N-terminus of the p10
subunit of caspase 3 can make contact with BIR2 the D214S
mutation to this region did not affect the ability of caspase 3
to bind XIAP in cells.
 
XIAP interaction with processed caspase 9
 
E314 and W310 are residues that contribute to the forma-
tion of a groove in the BIR3 of XIAP that is involved in
binding to the N terminus of DIABLO and processed cas-
pase 9, and neither E314S nor W310A mutants bind or in-
hibit processed caspase 9 in the context of the BIR3 alone
(Fig. 1, top) (Sun et al., 2000). H343A mutants also do not
inhibit caspase 9 in the context of the BIR3 but as H343 is not
present in the groove, this residue must contact another im-
portant surface of active caspase 9, perhaps acting in a man-
ner analogous to the D148 residue in caspase 3 inhibition.
To determine whether E314S, W310A, or H343A affects 
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the ability of full-length XIAP to inhibit caspase 9, we tran-
siently transfected 293T cells with constructs expressing
XIAP mutants together with full-length caspase 9. Ectopic
expression of caspase 9 in 293T cells results in autoprocess-
ing of caspase 9, presumably because the large over expres-
sion drives dimerization and activation, and lysates contain
both unprocessed and processed caspase 9. This active cas-
pase 9 is toxic to 293T cells in a similar manner to the auto-
activating caspase 3.
After transfection, XIAP mutants were immunoprecipi-
tated and the presence of coimmunoprecipitated caspase 9
was determined by Western blot analysis using anti–caspase
9 antibodies. As observed previously (Ekert et al., 2001),
wild-type XIAP bound only to processed caspase 9, and,
consistent with the results observed for the BIR3 domain
alone (Sun et al., 2000), the E314S or W310A single point
mutants had greatly reduced ability to bind processed cas-
pase 9 (Fig. 2). Whenever E314S, W310A, or H343A were
combined with another mutant affecting either DIABLO
binding or caspase 3 inhibition, there was a significant re-
duction in the amount of processed caspase 9 accumulating
because of the inability of the mutant XIAPs to prevent cas-
pase 9 induced toxicity which, as expected, requires caspase
3. Importantly, the mutant combinations that had unmu-
tated W310, E314, or H343 were able to accumulate and
bind processed caspase 9.
The analogous residue to G306S (G269S) has been de-
scribed in the 
 
Drosophila
 
 DIAP1 to create a gain of function
Figure 1.  The D148A mutation abolishes the ability of full length XIAP to interact with caspase 3 in cells. (top)   , Schematic of XIAP 
showing the location of key residues and their role in binding to partner proteins;  , Strong contribution of residue to binding;  , Weak 
contribution of residue to binding;  , No contribution; ?, No interaction in crystal structure. An empty space indicates that this residue is not 
presumed to interact but has never been tested. The roles of particular residues in binding have only been tested in the context of domains of 
XIAP, the importance of these residues in the context of the full-length molecule, with the exception of D148A has not been looked at previously. 
The mutants described in this paper have been tested in vitro and Kis and KDs have been established and the relevant data is tabulated below 
the schematic. Caspase 3 inhibition is Ki data for mutant in the context of full-length XIAP (Silke et al., 2001), caspase 9 inhibition is IC50 data 
for mutant in the context of the BIR3 (Sun et al., 2000), DIABLO is KD data for a peptide of the NH2-terminal of DIABLO binding to mutant in 
the context of the BIR3 domain of XIAP (Liu et al., 2000). (bottom) 293T cells were transiently transfected with plasmids expressing FLAG 
XIAP, FLAG XIAP mutants, or FLAG TAB1 and caspase 3 LacZ. Cell lysates were immunoprecipitated with anti-FLAG beads, separated on 
SDS/PAGE gels, transferred to PVDF membranes, and immunoblotted with anti–caspase 3 and anti-FLAG. 
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mutant (Goyal et al., 2000) that is a strong suppressor of
Grim and Reaper–induced cell death. Mammalian XIAP
D148A G306S binds processed caspase 9 as weakly as an
E314S mutant does in this immunoprecipitation assay. A
BIR3 domain containing an H343A mutation in the con-
text of the BIR3 alone fails to inhibit caspase 9, with an
IC50 of 
 
 
 
1 
 
 
 
M (Fig. 1, top) (Sun et al., 2000). In the con-
text of the full-length protein, H343A XIAP still appears to
be able to bind caspase 9, if due account is taken for the lev-
els of XIAP protein in the immunoprecipitation (Fig. 2). How-
ever, on three independent occasions we have observed that
none of the H343A mutants accumulate to the same levels
as wild-type XIAP when coexpressed with caspase 9. Coex-
pression of caspase 3 or DIABLO does not affect levels of
H343A mutants, indicating that the reduced levels are most
likely due to the inability of these XIAP mutants to inhibit
caspase 9 (Figs. 1 B and 3).
 
XIAP interaction with DIABLO/smac
 
Three regions of DIABLO have been implicated in interac-
tions with XIAP. DIABLO has been shown to bind XIAP
with a preference for the BIR3 (Chai et al., 2000; Srinivasula
et al., 2000). The processed N-terminal finger of DIABLO
contacts the same residues of the BIR3 that the processed
end of the p10 of caspase 9 does, namely E314 and W310
(Liu et al., 2000; Wu et al., 2000). The middle portion of
Figure 2.  The E314S, W310A, and G306S mutations significantly impair the ability of full length XIAP to interact with and inhibit processed 
caspase 9. 293T cells were transiently transfected with plasmids expressing FLAG-tagged XIAP, FLAG XIAP mutants, or FLAG TAB1 and 
caspase 9. Cell lysates were immunoprecipitated with anti-FLAG beads, separated on SDS/PAGE gels, transferred to PVDF membranes, and 
immunoblotted with anti–caspase 9 and anti-FLAG.
Figure 3.  The E314S, W310A mutations impair, and the D214S E314S combination abolishes the ability of full-length XIAP to interact 
with processed DIABLO. 293T cells were transiently transfected with plasmids expressing FLAG XIAP, FLAG XIAP mutants, FLAG TAB1, or 
FLAG CrmA and HA-tagged DIABLO. Cell lysates were immunoprecipitated with anti-FLAG beads, separated on SDS/PAGE gels, transferred 
to PVDF membranes, and then immunoblotted with anti-HA and anti-FLAG. 
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helices H2 and H3 in DIABLO also make contact with resi-
dues N259, S261, and R258 in the linker region immedi-
ately N-terminal to the BIR3 of XIAP (Wu et al., 2000). Fi-
nally, it has been proposed that the finger of DIABLO may
also contact D214 in the groove of BIR2, in an analogous
fashion to its interactions with E314 in the groove of BIR3.
To determine the importance of each of these contact points
in full-length XIAP we performed cotransfection analysis
with the XIAP mutants and DIABLO followed by coimmu-
noprecipitation and Western blotting (Fig. 3). Mutation of
either N259 or D214 alone did not significantly impair the
ability of XIAP to bind processed DIABLO, confirming that
the groove on BIR3 is the most important site. The N259D
E314S double mutant was impaired in its interaction with
DIABLO, but this would appear to be attributable to the
presence of the E314S mutation as similar impairment was
observed for the E314S, W310A E314S mutants and for
BIR2 linker E314S double mutants, V146A E314S and
D148A E314S (Fig. 3). Mutation of the BIR2 linker region
alone has been previously shown to have no effect on DI-
ABLO interaction (Silke et al., 2001). Although mutation of
E314 in XIAP significantly impairs interaction with DI-
ABLO, it does not eliminate interaction, and the amount of
DIABLO immunoprecipitated by the E314S mutant varied
between 5–50% depending upon the amount of processed
DIABLO in the lysate. The residual interaction is presum-
ably because DIABLO is also able to interact with the BIR2
domain. Simultaneous mutation of the predicted BIR2
binding site (D214S) and BIR3 binding site, E314S, com-
pletely eliminates XIAP interaction with DIABLO (Fig. 3).
These results indicate that the most important interaction of
DIABLO with XIAP is via the groove in BIR3, but there is
also a significant interaction with the analogous groove of
BIR2 and that the combination of D214S E314S eliminates
interaction of XIAP with DIABLO. Similar data have been
obtained for HtrA2/Omi (Verhagen et al., 2001).
 
XIAP oligomerization
 
As OpIAP has been described to form oligomers (Hozak et
al., 2000) we wanted to determine whether XIAP exists as
dimers or higher order oligomers within cells. In a transient
transfection and immunoprecipitation analysis, wild-type
XIAP is able to bind to itself (Fig. 4). We also determined
whether any of the mutations affected the ability of the mu-
tant XIAPs to bind to wild-type XIAP. Consistent with the
fact that none of the point mutations should affect the struc-
ture of XIAP, all of the mutants tested behaved indistin-
guishably from wild-type XIAP in their ability to bind wild-
type XIAP (Fig. 4). This interaction is likely to be specific
and not an overexpression artifact, as 
 
 
 
RING c-iap1 did not
interact with XIAP even though expressed to higher levels
than the full-length XIAP. Although it is possible that the
observed XIAP self-interaction is an indirect result of aggre-
gation in the apoptosome, the inability of the mutant
D148A D214S W310A E314S to bind caspase 3 (Fig. 1 B)
and caspase 9 (Fig. 2) suggests that the interaction between
different XIAP molecules is direct.
 
Ability of XIAP mutants to prevent apoptosis
 
The purpose of testing mutants in immunoprecipitation
analyses was to confirm within mammalian cells that the
constructs performed consistently. Nearly all of the muta-
tions have been described and rigorously tested in vitro (Fig.
1 A), and thus in most cases the assays were not designed to
test interaction but control that the construct had the muta-
tion in question. This was also the purpose behind including
several mutants that should behave analogously, thus the tri-
ple mutant D148A D214S E314S should perform the same
as either D148A D214S W310A or D148A D214S W310A
E314S as all target exactly the same interactions. Therefore,
the three mutants can be considered to belong to a single
class, and in Table I the mutants are grouped into classes so
that easy comparison of the results from the mutants is pos-
Figure 4.  XIAP is able to oligomerize in cells, and neither a D148A, D214S, N259D, W310, E314S, or H343A mutation, nor any combination 
thereof affects the ability of full-length XIAP to interact with itself. 293T cells were transiently transfected with plasmids expressing FLAG 
XIAP, FLAG XIAP mutants, FLAG c-iap1  RING, or FLAG CrmA, and HA-tagged XIAP wild-type. Cell lysates were immunoprecipitated with 
anti-FLAG beads, separated on SDS/PAGE gels, transferred to PVDF membranes, and immunoblotted with anti-HA and anti-FLAG. 
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sible. In all cases, the mutants performed consistently and
we were thus in a position to assay these mutants in a physi-
ological apoptosis setting.
To test whether loss of caspase 3, caspase 9, or DIABLO
binding affected the ability of XIAP to inhibit apoptosis in
mammalian cells, we expressed the mutants in NT2 terato-
carcinoma cells and exposed them to UV radiation or etopo-
side (Fig. 5). After 8 or 24 h (in the case of etoposide), all
cells were collected and stained with Annexin V and analy-
sed by flow cytometry, with transfected (GFP positive) cells
classed as apoptotic or viable based on their annexin bind-
ing. A representative sample of the data obtained is shown in
Fig. 5 A. These experiments were repeated on three indepen-
dent occasions and the mean and standard deviation calcu-
lated for each mutant (Fig. 5, B and C).
We have previously shown that loss of caspase 3 inhibition
does not affect XIAPs ability to prevent UV-induced cell
death (Silke et al., 2001) and in this study the double mu-
tant D148A D214S is also unimpaired. Likewise, loss of the
ability to inhibit caspase 9 alone did not affect the ability of
the mutants to inhibit apoptosis, because neither E314S
XIAP, H343A XIAP, nor the W310A E314S double mutant
were impaired in their ability to protect the cells. Loss of
ability to bind DIABLO/caspase 9 did affect XIAP function
in inhibiting cell death because the D214S E314S double
and the D214S W310A E314S, D214S N259D E314S tri-
ple mutants while still able to inhibit cell death, were not as
competent as the wild-type protein.
Any XIAP mutant that contained the combination of the
D148A and E314S (or W310A) mutations, and therefore
had lost the ability to inhibit both caspase 3 and caspase 9,
was impaired in its ability to inhibit cell death. Mutations
within the BIR2 linker region that are not as compromised
in their ability to inhibit caspase 3 as D148A, i.e., V146A
and T143A (Silke et al., 2001), when combined with
E314S, also reduced the ability of XIAP to inhibit cell death
(Fig. 5, A and B). These double mutants provide a type of
dose-response and confirm in an independent fashion that
simultaneous loss of the ability to inhibit caspase 3 and cas-
pase 9 markedly reduces the potential of XIAP to inhibit cell
 
Table I.
 
Summary of the properties of XIAP mutants
Class of mutant
Average 
UV 
death
Average 
Etoposide 
death
DIABLO 
binding
Casp3 
Inhibition
Casp9 
Inhibition
XIAP 
binding
 
%%
Vector 79 50 ————
NT2 cells 69 52 ————
Wild-type
XIAP 11 5 10 10 10 10
XIAP N259D 10 3 10 10 10 10
Caspase 9 only
XIAP H343A 11 — 10 10 0 10
Part DIABLO
XIAP D214S 9 3 9 10 10 10
XIAP D214S N259D 11 3 9 10 10 10
Caspase 9 and part DIABLO
XIAP E314S 13 6 5 10 0 10
XIAP N259D E314S 14 5 5 10 0 10
XIAP W310A E314S 16 6 4 10 0 —
XIAP D214S H343A 11 — 8 10 0 10
Caspase 9 and DIABLO
XIAP D214S E314S 23 10 0 10 0 10
XIAP D214S N259D E314S 24 9 0 10 0 10
XIAP D214S W310A E314S 33 18 0 10 0 10
Caspase 3, caspase 9, and part DIABLO
XIAP T143A E314S 29 24 5 5 0 —
XIAP V146A E314S 32 26 5 2 0 —
XIAP D148A E314S 50 46 5 0 0 —
XIAP D148A W310A E314S 49 56 4 0 0 —
XIAP D148A D214S H343A 15 — 9 0 0 10
XIAP D148A G306S 13 5800 1 0
Caspase 3, caspase 9, and DIABLO
XIAP D148A D214S E314S 67 52 0 0 0 10
XIAP D148A D214S W310A 65 50 0 0 0 10
XIAP D148A D214S W310A E314S 70 49 0 0 0 10
Caspase 3 and caspase 9
XIAP 9 — 10 0 0 10
Mutants are grouped into classes to allow easy comparison of data between particular sets of mutants. N259D has been allocated as wild-type because it
had no apparent effect on DIABLO binding. Arbitrary values for XIAP binding or inhibition have been allocated based on consideration of previously
unpublished in vitro inhibition data and binding data presented in this paper, with 10 representing 100%, and 0 representing 0%, relative to wild-type XIAP.
The mean apoptosis is the data presented in bar graph format in Fig. 5, A and B. 
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death. However, it is significant that the E314S/W310A
mutant also interferes with XIAPs ability to bind DIABLO/
smac, although it does not abrogate it entirely. Therefore,
these mutants are grouped in the loss of caspase 3, caspase 9
and part loss of DIABLO binding class in Table I.
Triple mutants that had completely lost their ability to
bind not only caspase 3 and caspase 9 but also DIABLO/
smac were completely ineffective in blocking either UV or
etoposide induced apoptosis, confirming that the essential
points of XIAP inhibition of cell death are controlled
through these three interactions.
Two types of mutants that have lost the ability to inhibit
caspase 9 but retain the ability to bind DIABLO (the D148
G306S double mutant and the H343A double and triple
mutants) were notable because they were still able to inhibit
apoptosis as effectively as wild type XIAP.
 
RING finger function
 
To assess the function of the RING finger in XIAPs ability
to inhibit UV-induced apoptosis we created XIAP point
mutants without the RING finger. The 
 
 
 
RING point mu-
tants were assayed at the same time as the full-length XIAP
mutants, and comparison of Figs. 5 B and 6 A shows that
the full-length mutants gave the same levels of protection
as before. Altogether, the 
 
 
 
RING mutants performed simi-
larly to the full-length protein with single mutants protect-
ing as well as wild-type XIAP, and the triple D148A
D214S E314S mutant having lost the ability to inhi-
bit UV-induced apoptosis (Fig. 6 A). Interestingly, the
D148A E314S 
 
 
 
RING protected better than the full-
length protein. This was most likely due to the increased
stability/expression of the 
 
 
 
RING mutants in NT2 cells
(Fig. 6 B).
Figure 5.  XIAP that is competent to 
bind DIABLO is able to inhibit cell 
death. (A) FACS analysis of transiently 
transfected NT2 cells stained with 
Annexin V 8 h after UV irradiation. (B) 
The ability of XIAP mutants to protect 
against UV induced death. NT2 cells 
were transiently transfected with FLAG 
XIAP (wt XIAP), FLAG XIAP mutants, 
empty vector (vector), DIABLO/smac 
(DIABLO), or were untransfected (cells). 
Cells were subsequently irradiated with 
UV, and stained with Annexin V 7–8 h 
later. The fraction of cells that were 
positive for GFP and Annexin V over 
total number of GFP positive cells were 
expressed as the percent of Annexin V 
positive cells, except in the case of un-
transfected cells where the percent of 
Annexin V positive cells over the total 
number of cells were expressed as the 
percent of Annexin V positive cells. Error 
bars are standard deviation for three
independent experiments. Different 
classes of mutants are indicated by 
different shading to enable easy 
comparison. (unfilled bars) Mutants that 
do not inhibit caspase 3, caspase 9 or 
DIABLO. (dark shaded bars) Mutants 
that affect caspase 3, caspase 9, and also 
affect DIABLO binding. (hatched bars) 
Mutants that affect caspase 3 and
caspase 9 only. (C) The ability of XIAP 
mutants to protect against etoposide 
induced death. As above for UV-induced 
death except NT2 cells were rather 
incubated with etoposide for 20–24 h 
and then stained with Annexin V. 
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To study oligomerization with wild-type XIAP we per-
formed coimmunoprecipitation analyses as before. Signifi-
cantly, the 
 
 
 
RING mutants were impaired in their ability to
dimerize, even though their expression levels were if any-
thing slightly above those of the full-length protein. Thus, it
appears that the RING finger promotes XIAP oligomeriza-
tion but is not required for XIAP to inhibit cell death.
 
Discussion
 
An array of single point mutations that should not affect the
structure of XIAP (Sun et al., 1999, 2000) and do not affect
its ability to oligomerize (Fig. 4), were used to analyze many
of the distinct functions of XIAP in isolation. These results
show that an XIAP mutant that cannot inhibit caspase 3,
caspase 9, and DIABLO is no longer able to inhibit UV or
etoposide induced cell death.
Mutation of D148 in the N-terminal flank of BIR2 pre-
vents XIAP interacting with processed caspase 3 (Sun et al.,
1999), but leaves intact binding to processed caspase 9, DI-
ABLO, (Silke et al., 2001), XIAP (Fig. 4), and TAB1 (un-
published data). The structure of the BIR2 of XIAP bound
to caspase 3 (Riedl et al., 2001) indicates that, aside from
D148, residues in the D214 groove in the core of BIR2
make contact with the processed N-terminus of the p10 of
caspase 3. However, in this case the processed p10 of caspase
3 would contact a BIR2 in a different XIAP molecule to the
BIR2 that binds via its N-terminal flank to the active site of
caspase 3. In other words, the structure implies that XIAP
exists as a multimer when it is bound to processed caspase 3.
At least in the context of the full-length molecule, mutation
of D214 does not drastically affect the ability of XIAP to in-
hibit caspase 3 because a D214S E314S XIAP double point
mutant (in which the grooves in both BIR2 and BIR3 are
mutated) is able to inhibit cell death much better than a
D148A E314S double mutant (Fig. 6, A and B). This result
is in accord with an analysis of the BIR2 alone, in which
mutation of D214 did not affect the ability of the BIR2 to
inhibit caspase 3 (Sun et al., 1999).
The crystal structure of DIABLO bound to the BIR3 of
XIAP has been solved and shows that in addition to E314
and W310 other residues also make contact with DIABLO
(Wu et al., 2000; Srinivasula et al., 2001). In particular, the
middle portion of helices H2 and H3 in DIABLO makes
contacts via amino acids in its helix domain to residues
N259, S261, and R258 of the BIR3 of XIAP. Although this
interface consists of seven hydrogen bonds and two patches
of van der Waals interactions, with 
 
 
 
2,000 A
 
2
 
 of buried sur-
face area, mutation of N259 alone makes little difference to
the ability of XIAP to bind DIABLO. Furthermore, the
N259D D214S and N259D E314S double mutants still
bind DIABLO, indicating that the contribution of N259 in
the full-length molecule is not as significant as either D214
or E314. In contrast, the D214S E314S double mutant has
completely lost the ability to bind DIABLO, indicating that
the grooves in BIR2 and BIR3 make the most critical con-
tacts to DIABLO. We have also recently shown that the
D214S E314S double mutant is incapable of binding an-
other IAP antagonist HtrA2/Omi (Verhagen et al., 2001).
Although simultaneous mutation of D214 and E314 abol-
ishes DIABLO, HtrA2/Omi binding (Verhagen et al., 2001)
and simultaneously caspase 9 binding, it nevertheless only
slightly affects the ability of the overexpressed XIAP to in-
hibit cell death (Fig. 5, B and C). Thus, overexpressed XIAP
can partially inhibit cell death by blocking caspase 3 alone,
which is consistent with the idea that there is a feedback
loop where caspase 3 can process caspase 9.
Both DIABLO and caspase 9 contact E314 in the groove of
BIR3 (Wu et al., 2000). However, E314 is clearly more criti-
Figure 6.   RING XIAP is as competent as full-length XIAP to
inhibit cell death, but is impaired in its ability to oligomerize. (A) 
FACS analysis of transiently transfected NT2 cells stained with 
Annexin V 8 h after UV irradiation. The full-length protein is 
indicated with unfilled bars and the  RING mutants with gray bars. 
(B) Western blot of transiently transfected NT2 cell extracts separated 
on SDS/PAGE gels and probed with anti-FLAG, samples are loaded 
as in the UV assay above, the lower molecular weight band 
detected by the flag antibody is present in both full-length XIAP and 
 RING mutants and might represent a cleavage product of XIAP 
although the cells were not treated with any apoptotic stimulus. 
(C) 293T cells were transiently transfected with plasmids expressing 
FLAG XIAP  RING, FLAG XIAP  RING mutants, FLAG c-iap1 
 RING, or FLAG CrmA and HA-tagged XIAP wild-type. Cell lysates 
were immunoprecipitated with anti-FLAG beads, separated on 
SDS/PAGE gels, transferred to PVDF membranes, and immunoblotted 
with anti-HA. 
XIAP interactions required to inhibit cell death |
 
 Silke et al. 123
 
cal for caspase 9 binding because the E314S mutation alone
completely abolishes the ability of XIAP to immunoprecipi-
tate processed caspase 9, whereas it leaves some DIABLO
binding intact (compare Figs. 2 and 3). G306 is also present
in the BIR3 groove and makes contacts to the fourth residue
(Ile57) of the processed N-terminal of DIABLO (Liu et al.,
2000; Wu et al., 2000). Mutation of Ile57 impairs DIABLO
N-terminal peptide binding to the BIR3 of XIAP, but is
 
 
 
100-fold less disruptive than mutation of the first residue of
processed DIABLO (Ala54). E314 and W310 of XIAP con-
tact Ala54 of DIABLO, whereas G306 contacts Ile57, thus it
is likely that the G306S XIAP binds DIABLO better than the
E314S or W310A mutants (Liu et al., 2000). Furthermore,
the G306S is likely to be more disruptive of the bulky Phe in
the fourth position of processed caspase 9 (Srinivasula et al.,
2001) than the Ile of DIABLO or the Ala of HtrA2. H343A
does not affect binding of the N-terminal peptide of DI-
ABLO to the BIR3 of XIAP (Liu et al., 2000).
E314S and W310A mutations both simultaneously inter-
fere with DIABLO and caspase 9 binding. In the UV death
assay, both the D148A E314S and D148A W310A E314S
mutants still protect partially even though they have lost cas-
pase 3 and caspase 9 binding and have reduced DIABLO
binding. The protection the D148A E314S mutant affords
can be further increased by deleting the RING finger of
XIAP (Fig. 6 A) which increases the levels of XIAP in NT2
cells (Fig. 6 B). This indicates that even residual DIABLO
binding is sufficient to partially block apoptosis. The mu-
tants G306S and H343A further confirm that DIABLO
binding is sufficient for exogenous XIAP to block cell death.
In these cases, either the double mutants D148A G306S,
D148A H343A or the triple mutant D148A D214S
H343A, which retain significant DIABLO binding, still
protect NT2 cells as well as wild-type XIAP against UV-
induced cell death.
Deletion of the RING finger has little effect on the ability
to inhibit UV-induced cell death. As with fly DIAP1 (Hay et
al., 1995), removal of the RING finger makes XIAP a margin-
ally more potent inhibitor of cell death, presumably due to its
increased abundance. Contrary to OpIAP (Hozak et al.,
2000), we find that the RING finger makes a strong contribu-
tion to XIAPs ability to oligomerize and 
 
 
 
RING c-iap1 does
not interact at all. These results mean that oligomerization of
the full-length protein is likely to be physiological, and at least
in the context of this assay, that the ability to oligomerize is
not required for XIAP to inhibit cell death.
Because an IAP that has lost the ability to bind caspase 3,
caspase 9, DIABLO and HtrA2/Omi is ineffective at block-
ing UV cell death, all of XIAPs anti-apoptotic activity must
reside in these functions. By selectively removing the ability
to inhibit caspase 3 and caspase 9, we have created several
XIAP mutants that can only bind IAP antagonists, and these
mutants still inhibit cell death as well as wild-type XIAP.
The most likely mechanism for this inhibition is that exoge-
nous expression of these mutants is sufficient to bind IAP
antagonists that are released after a death stimulus such as
DIABLO/smac and HtrA2/Omi, thereby allowing endoge-
nous IAPs to block caspases without being antagonized. As
there are several other IAP antagonists in addition to DI-
ABLO and HtrA2/Omi (unpublished data), it might be dif-
ficult to prove the requirement for IAP antagonism by
knock-out strategies alone. Therefore, these results demon-
strate a requirement for IAP antagonism in cell death and
indicate that the XIAP mutants described here will be useful
tools in other similar analyses.
 
Materials and methods
 
Transfections and constructs
 
pEF expression constructs encoding C-terminal FLAG-tagged XIAP, N-ter-
minally FLAG-tagged CrmA DQMD, caspase 3 LacZ, caspase 9, and
pFLAG TAB1 have been previously described (Ekert et al., 1999; Verhagen
et al., 2000; Silke et al., 2001). pEF TAB1 HA Tag was constructed by di-
gesting the PCR product of primers 226 TAB1 5
 
 
 
 cgggatccaccatggcggcgca-
gaggaggag 3
 
 
 
 and 227 TAB1 5
 
 
 
 cgcgctagccggtgctgtcaccacgctctgct 3
 
 
 
 with
 
Bam
 
H I, 
 
Nhe
 
 I and cloning into pEF HA Tag digested with 
 
Bam
 
H I, 
 
Nhe
 
 I.
pEF constructs encoding FLAG-tagged XIAP mutants were generated using
overlap PCR technology. The D148A construct has already been described
(Silke et al., 2001). The other mutants were generated with combina-
tions of the primers 759 
 
BstB
 
 I 5
 
 
 
 tgcttctttgttttgggccgga 3
 
 
 
, 760 E314S
5
 
 
 
 aactgattggaagcccagttccgacccttgggaacaacatgct 3
 
 
 
, 766 W310A 5
 
 
 
tggaggagggctaactgatgcgaagcccagtgaagacc 3
 
 
 
, 770 
 
Eco
 
R V 5
 
 
 
 ctgtctttctgag-
cattcactagat 3
 
 
 
, 771 D214S 5
 
 
 
 tgggaaccttgctcgagagcctggtcagaacacag 3
 
 
 
,
and 772 N259D 5
 
 
 
 tcaacaaatcttcctcgagatccatccatggcagatta 3
 
 
 
,
 
 
 
and in-
serted into pEF FLAG XIAP digested with 
 
Bst
 
B I and 
 
Eco
 
R V. FLAG-tagged
XIAP domain constructs were generated using PfuI polymerase PCR, and
the primers 743 BIR2 5
 
 
 
 cgggatccaccatgcgtgatcattttgccttagacag 3
 
 
 
, 744
BIR2 5
 
 
 
 cgcgctagctggattcctaggaagatttgttgaatttggg 3
 
 
 
, 771 BIR1 5
 
 
 
cgggatccaccatgacttttaacagttttgaaggatcta 3
 
 
 
, 745 BIR1 5
 
 
 
 ccgcc-
ctaggggcaaaaagatctctgcttcccagatagtt 3
 
 
 
, 747 BIR3 5
 
 
 
 ccgccctaggaatc-
catccatggcagattat 3
 
 , 750 XIAP 5  cgtctagacataaaaattttttgcttgaa 3 , 761
BIR3 5  cggaattcggatccaccatgtctgatgctgtgagttc 3 ,  and 762 BIR3 5 
gcgttagctagcggagatctgagtagttcttaccagacact 3  and cloned into the vector
pEF c-term FLAG using sites compatible with BamH I and Nhe I. pEF XIAP
 RING constructs were made using PCR primers 746 5  cgggatccaccat-
gacttttaacagttttgaaggatcta 3  and 762 and cloned BamH I Nhe I into pEF
C-terminal FLAG digested with BamH I Xba I. All constructs were verified
by digest and sequencing.
Immunoprecipitations and Western blot analysis
Cells were lysed in a Triton X-100 based lysis buffer (1% Triton X-100,
10% glycerol, 150 mM NaCl, 20 mM Tris, pH 7.5, 2 mM EDTA, 1 mM
PMSF, 10  g/ml aprotinin and 10  g/ml leupeptin) for 1 h at 4 C and the
debris cleared by centrifugation. Immunoprecipitations were performed
using FLAG specific mAb M2 covalently coupled agarose beads (Sigma-
Aldrich). The immunoprecipitates were washed five times in lysis buffer
and proteins eluted with 100 mM glycine, pH 3, and then neutralized with
1/10th vol of 1 M Tris, pH 8. Proteins were separated by SDS PAGE and
immunoprecipitates were examined by Western blot analysis after transfer
of proteins to Immobilon™-P membranes (Millipore). Antibodies used for
Western blots were anti-FLAG M2 (Sigma-Aldrich), anti-HA High Affinity
3F10 (Boehringer Mannheim), anti–caspase 9, a gift of Y. Lazebnik, and
anti–caspase 3 (Pharmingen). Proteins were visualized by ECL (Amersham
Pharmacia Biotech) after incubation of membranes with HRP-coupled sec-
ondary antibodies.
Apoptosis assays
The cell death assay is described in detail in Silke et al. (2001). In brief,
NT2 cells were transfected with equal amounts of the mutant constructs
and 1:20 (wt/wt) of pEGFP for 24 h. The cells were washed and induced to
undergo apoptosis by irradiating with 25 J/m
2 of UV and harvested 6–7 h
later, or treating with etoposide (100  g/ml) and harvesting 20–24 h later.
All cells, both adherent and nonadherent, were recovered and stained with
recombinant Annexin V-Biotin and streptavidin Tricolor (CalTag Laborato-
ries) with appropriate washing steps. The stained cells were analysed with
a FACs scan for FL1 fluorescence (EGFP positive) and FL3 fluorescence
(Annexin V positive) and the proportion of cells that were EGFP and An-
nexin V positive (transfected and apoptotic), to the total of EGFP positive
(transfected) cells was determined.
Software
An EPSON scanner was used to scan all autoradiographs and the scanned
images were imported directly into FreeHand9 and cropped with
Freehand9.124 The Journal of Cell Biology | Volume 157, Number 1, 2002
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